Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07185282
What this trial is testing

MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Minghui Pharmaceutical (Hangzhou) Ltd 375
Large-scale testing (Phase 3)Study completedNCT06238817
What this trial is testing

Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 241
Early research (Phase 1)Study completedNCT04135560
What this trial is testing

Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

Who this might be right for
Dermatitis Atopic
Pfizer 34
Not applicableStudy completedNCT04295824
What this trial is testing

Skin Pathology Assessment With Optical Technologies

Who this might be right for
Atopic Dermatitis Eczema
Sheffield Teaching Hospitals NHS Foundation Trust 80
Not applicableStudy completedNCT04553224
What this trial is testing

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 17
Testing effectiveness (Phase 2)Study completedNCT07103174
What this trial is testing

MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Mabgeek Biotech.Co.Ltd 60
Large-scale testing (Phase 3)Study completedNCT00480610
What this trial is testing

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 226
Early research (Phase 1)Study completedNCT04081350
What this trial is testing

LY3471851 in Participants With Eczema

Who this might be right for
Dermatitis, Atopic
Nektar Therapeutics 48
Not applicableLooking for participantsNCT07754968
What this trial is testing

Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis

Who this might be right for
Infant ColicAtopic Dermatitis
University of Roma La Sapienza 64
Not applicableEnded earlyNCT06155513
What this trial is testing

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

Who this might be right for
Eczema
SCF Pharma 7
Testing effectiveness (Phase 2)UnknownNCT05702268
What this trial is testing

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 75
Large-scale testing (Phase 3)WithdrawnNCT05219864
What this trial is testing

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1

Who this might be right for
Hand Eczema
Incyte Corporation
Not applicableStudy completedNCT05783453
What this trial is testing

CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

Who this might be right for
Atopic Dermatitis
Cosmetique Active International 63
Not applicableUnknownNCT04681300
What this trial is testing

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Who this might be right for
Prurigo NodularisAtopic Dermatitis
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06407934
What this trial is testing

Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 1,541
Not applicableStudy completedNCT05530707
What this trial is testing

Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer

Who this might be right for
Atopic Dermatitis
Farmoquimica S.A. 49
Large-scale testing (Phase 3)Study completedNCT04468711
What this trial is testing

Vitamin D in Egyptian Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
National Hepatology & Tropical Medicine Research Institute 92
Not applicableStudy completedNCT04226092
What this trial is testing

Pre-SunBeam TEWL AUC

Who this might be right for
Atopic Dermatitis
Northwestern University 33
Post-approval studies (Phase 4)Study completedNCT01202149
What this trial is testing

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

Who this might be right for
EczemaAtopic Dermatitis
Frankel, Amylynne, M.D. 30
Large-scale testing (Phase 3)Study completedNCT00232063
What this trial is testing

Long-term Study of Ciclosporin for Atopic Dermatitis

Who this might be right for
Severe Atopic Dermatitis
Novartis Pharmaceuticals
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation